Xbrane And Stada Seek Fresh Ranibizumab Partner In North America

New Search For Commercialization Alliance Comes After Bausch+Lomb Drops Deal

 
• By Dave Wallace

Xbrane and Stada have announced that they are seeking a new North American partner for their biosimilar ranibizumab candidate after agreeing to discontinue a deal with Bausch+Lomb.

Magnifying glass over small model people shaking hands and making a deal, against bright yellow background
Xbrane and Stada are seeking a new North American partner • Source: Shutterstock

More from Biosimilars

More from Products